INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | -33.3% | 157 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | -40.0% | 171 | +2.4% | 0.00% | -33.3% |
| Q4 2021 | $20,000 | -4.8% | 167 | +7.7% | 0.00% | -25.0% |
| Q3 2021 | $21,000 | -8.7% | 155 | +8.4% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | +187.5% | 143 | +43.0% | 0.00% | +100.0% |
| Q1 2021 | $8,000 | +60.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $5,000 | +150.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -99.0% | 100 | -99.4% | 0.00% | -98.9% |
| Q1 2020 | $197,000 | +19.4% | 16,108 | +43.6% | 0.09% | +45.2% |
| Q4 2019 | $165,000 | +587.5% | 11,215 | +647.7% | 0.06% | +520.0% |
| Q2 2019 | $24,000 | -68.0% | 1,500 | -72.7% | 0.01% | -79.6% |
| Q4 2018 | $75,000 | -35.3% | 5,495 | +35.8% | 0.05% | -29.0% |
| Q3 2018 | $116,000 | – | 4,045 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |